You are currently viewing a new version of our website. To view the old version click .

Non-coding RNAs in Cancer: Markers in Disease Progression and Therapy

Topic Information

Dear Colleagues,

Non-coding RNAs like miRNA, lncRNA or circRNA have been shown to be important regulators of gene expression. They are involved in regulation of fundamental physiological processes, and increasing evidence showed the significant role of ncRNAs in various diseases including cancer. However, considering the large number of existing ncRNAs, only a part of these molecules has been studied with regard to their role in cancer. In addition to further identification of their specific interactors, the role of ncRNAs as cancer markers and potential therapy targets is of high importance.

The Special Issue would like to focus on the following topics:

  • Effect of specific ncRNAs on progression of different cancer entities: underlying molecular mechanisms
  • Role of ncRNAs as cancer markers and therapy targets
  • Role of circRNAs in cancer (since this ncRNA type has been least studied due to its late discovery)
  • Role of competing endogenous RNAs (ceRNA) affecting miRNA action and mRNA expression in terms of tumor progression, diagnosis, and therapy
  • Creating a database of lncRNA/circRNA interaction with specific miRNAs targets, as a tool to facilitate studies on the role of ncRNAs in cancer progression and therapy

Keywords

  • ceRNA
  • lncRNA
  • circRNA
  • miRNA
  • mRNA
  • cancer

Participating Journals

Biomedicines
Open Access
15,153 Articles
Launched in 2013
3.9Impact Factor
6.8CiteScore
17 DaysMedian Time to First Decision
Q1Highest JCR Category Ranking
Cancers
Open Access
33,773 Articles
Launched in 2009
4.4Impact Factor
8.8CiteScore
20 DaysMedian Time to First Decision
Q2Highest JCR Category Ranking
Current Oncology
Open Access
5,029 Articles
Launched in 1994
3.4Impact Factor
4.9CiteScore
21 DaysMedian Time to First Decision
Q2Highest JCR Category Ranking
Non-Coding RNA
Open Access
580 Articles
Launched in 2015
3.0Impact Factor
7.4CiteScore
23 DaysMedian Time to First Decision
Q2Highest JCR Category Ranking
Onco
Open Access
127 Articles
Launched in 2021
-Impact Factor
-CiteScore
21 DaysMedian Time to First Decision
-Highest JCR Category Ranking

Published Papers